Hypophosphatasia update: Recent advances in diagnosis and treatment

Clinical Genetics

Volumn 73, Issue 3, 2008, Pages 232-235

  Cole, David E C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE ISOENZYME; ALKALINE PHOSPHATASE PLACENTA ISOENZYME; INORGANIC PYROPHOSPHATASE; NONSTEROID ANTIINFLAMMATORY AGENT; PARATHYROID HORMONE[1-34]; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BLOOD BRAIN BARRIER; BONE CANCER; BONE MARROW TRANSPLANTATION; BONE METABOLISM; BONE MINERALIZATION; CLEIDOCRANIAL DYSPLASIA; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME REPLACEMENT; GENE INTERACTION; GENE MUTATION; GENETIC COUNSELING; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HUMAN; HYPOPHOSPHATASIA; HYPOPHOSPHATEMIA; INBORN ERROR OF METABOLISM; INFANT DISEASE; MINERAL METABOLISM; NONHUMAN; OSTEOGENESIS IMPERFECTA; OSTEOMYELITIS; OSTEOPOROSIS; PHENOTYPE; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; PSEUDOHYPOPHOSPHATASIA; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

ALKALINE PHOSPHATASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE AND BONES; GENETIC SCREENING; HUMANS; HYPOPHOSPHATASIA; MICE; MUTATION; PARATHYROID HORMONE;

EID: 38949099010     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00958.x     Document Type: Article

References (46)

1. Mumm S, Jones J, Finnegan P, Whyte MP. Hypophosphatasia: Molecular diagnosis of Rathbun's original case. J Bone Miner Res 2001: 16: 1724-1727.
2. Waymire KG, Mahuren JD, Jaje JM, Guilarte TR, Coburn SP, MacGregor GR. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet 1995: 11: 45-51.
3. Narisawa S, Frohlander N, Millan JL. Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 1997: 208: 432-446.
4. Fedde KN, Blair L, Silverstein J et al. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 1999: 14: 2015-2026.
5. Hough TA, Polewski M, Johnson K et al. A novel mouse model of autosomal semi-dominant adult hypophosphatasia has a splice site mutation in the tissue non-specific alkaline phosphatase gene Akp2. J Bone Miner Res 2007: 22: 1397-1407.
6. Nishioka T, Tomatsu S, Gutierrez MA et al. Enhancement of drug delivery to bone: Characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide. Mol Genet Metab 2006: 88: 244-255.
7. Anderson HC, Harmey D, Camacho NP et al. Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. Am J Pathol 2005: 166: 1711-1720.
8. Whyte MP. 'Hypophosphatasia'. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds. The metabolic and molecular bases of inherited disease, 8th edn. New York, NY: McGraw-Hill, 2001: 5313-5329.
9. Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Menez A, Le Du MH. Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization. J Biol Chem 2001: 276: 31171-31178.
10. Cole DEC. 'Hypophosphatasia'Chap. 27. In: Glorieux FH, Pettifor J, Juppner H, eds. Pediatric bone. Amsterdam: Academic Press, 2003: 651-678.
11. Millan, JL. Mammalian alkaline phosphatases: From biology to applications in medicine and biotechnology. Weinheim: Wiley-VCH, 2006.
12. Fonta C, Negyessy L, Renaud L, Barone P. Postnatal development of alkaline phosphatase activity correlates with the maturation of neurotransmission in the cerebral cortex. J Comp Neurol 2005: 486: 179-196.
13. Narisawa S, Wennberg C, Millan JL. Abnormal vitamin B6 metabolism in alkaline phosphatase knock-out mice causes multiple abnormalities, but not the impaired bone mineralization. J Pathol 2001: 193: 125-133.
14. 6 metabolism. J Clin Invest 1985: 76: 752-756.
15. Baumgartner-Sigl S, Haberlandt E, Mumm S et al. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone 2007: 40: 1655-1661.
16. Litmanovitz RO, Dolfin T, Arnon S et al. Glu274Lys/Gly309Arg mutation of the tissue-nonspecific alkaline phosphatase gene in neonatal hypophosphatasia associated with convulsions. J Inherit Metab Dis 2002: 25: 35-40.
17. Nunes ML, Mugnol F, Bica I, Fiori RM. Pyridoxine-dependent seizures associated with hypophosphatasia in a newborn. J Child Neurol 2002: 17: 222-224.
18. Yamamoto H, Sasamoto Y, Miyamoto Y, Murakami H, Kamiyama N. A successful treatment with pyridoxal phosphate for West syndrome in hypophosphatasia. Pediatr Neurol 2004: 30: 216-218.
19. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millán JL. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: An integrated model of the pathogenesis of mineralization disorders. Am J Pathol 2004: 164: 1199-1209.
20. Anderson HC, Sipe JB, Hessle L et al. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 2004: 164: 841-847.
21. Wennberg C, Hessle L, Lundberg P et al. Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J Bone Miner Res 2000: 15: 1879-1888.
22. Johnson KA, Hessle L, Vaingankar S et al. Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol 2000: 279: R1365-R1377.
23. Hessle L, Johnson KA, Anderson HC et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A 2002: 99: 9445-9449.
24. Sinico M, Levaillant JM, Vergnaud A et al. Specific osseous spurs in a lethal form of hypophosphatasia correlated with 3D prenatal ultrasonographic images. Prenat Diagn 2007: 27: 222-227.
25. Souka AP, Raymond FL, Mornet E, Geerts L, Nicolaides KH. Hypophosphatasia associated with increased nuchal translucency: A report of two affected pregnancies. Ultrasound Obstet Gynecol 2002: 20: 294-295.
26. van den Bos T, Handoko G, Niehof A et al. Cementum and dentin in hypophosphatasia. J Dent Res 2005: 84: 1021-1025.
27. Unger S, Mornet E, Mundlos S, Blaser S, Cole DE. Severe cleidocranial dysplasia can mimic hypophosphatasia. Eur J Pediatr 2002: 161: 623-626.
28. Morava E, Karteszi J, Weisenbach J, Caliebe A, Mundlos S, Mehes K. Cleidocranial dysplasia with decreased bone density and biochemical findings of hypophosphatasia. Eur J Pediatr 2002: 161: 619-622.
29. Spentchian M, Brun-Heath I, Taillandier A et al. Characterization of missense mutations and large deletions in the ALPL gene by sequencing and quantitative multiplex PCR of short fragments. Genet Test 2006: 10: 252-257.
30. Lia-Baldini AS, Muller F, Taillandier A et al. A molecular approach to dominance in hypophosphatasia. Hum Genet 2001: 109: 99-108.
31. Brun-Heath I, Chabrol E, Fox M et al. A case of lethal hypophosphatasia providing new insights into the perinatal benign form of hypophosphatasia and expression of the ALPL gene. Clin Genet 2007: (Epub ahead of print).
32. Goseki-Sone M, Sogabe N, Fukushi-Irie M et al. Functional analysis of the single nucleotide polymorphism (787T>C) in the tissue-nonspecific alkaline phosphatase gene associated with BMD. J Bone Miner Res 2005: 20: 773-782.
33. Whyte MP, Essmyer K, Geimer M, Mumm S. Homozygosity for TNSALP mutation 1348c>T (Arg433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry. J Pediatr 2006: 148: 753-758.
34. Pauli RM, Modaff P, Sipes SL, Whyte MP. Mild hypophosphatasia mimicking severe osteogenesis imperfecta in utero: Bent but not broken. Am J Med Genet 1999: 86: 434-438.
35. Comstock C, Bronsteen R, Lee W, Vettraino I. Mild hypophosphatasia in utero: Bent bones in a family with dental disease. J Ultrasound Med 2005: 24: 707-709.
36. Wenkert D, McAlister WH, Hersh JH, Mumm S, Whyte MP. Hypophosphatasia: misleading in utero presentation for the childhood and odonto forms [abstract]. J Bone Min Res 2005: 20 (Suppl. 1): S418.
37. Girschick HJ, Mornet E, Beer M, Warmuth-Metz M, Schneider P. Chronic multifocal non-bacterial osteomyelitis in hypophosphatasia mimicking malignancy. BMC Pediatr 2007: 7: 3.
38. Khandwala HM, Mumm S, Whyte MP. Low serum alkaline phosphatase activity and pathologic fracture: Case report and brief review of hypophosphatasia diagnosed in adulthood. Endocr Pract 2006: 12: 676-681.
39. Wenkert D, Podgornik MN, Coburn SP et al. Dietary phosphate restriction therapy for hypophosphatasia: Preliminary observations. J Bone Miner Res 2002: 17 (Suppl. 1): S384.
40. Whyte MP, Kurtzberg J, McAlister WH et al. Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 2003: 18: 624-636.
41. Cahill RA, Wenkert D, Perlman SA et al. Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts. J Clin Endocrinol Metab 2007: 92: 2923-2930.
42. Whyte MP, Mumm S, Deal C. Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab 2007: 92: 1203-1208.
43. Girschick H, Schneider P, Haubitz I et al. Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia. Orphanet J Rare Dis 2006: 1: 24.
44. Whyte MP, Valdes R Jr, Ryan LM, McAlister WH. Infantile hypophosphatasia: Enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone disease. J Pediatr 1982: 101: 379-386.
45. Whyte MP, McAlister WH, Patton LS et al. Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: Results in three additional patients. J Pediatr 1984: 105: 926-933.
46. Millan JL, Narisawa S, Lemire I et al. Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res 2007: 22 (Suppl. 1): S72.